A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice

Genes and Development

Volumn 12, Issue 23, 1998, Pages 3675-3685

  Holland, Eric C ^a,c   Hively, Wendy P ^a   DePinho, Ronald A ^b   Varmus, Harold E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cell cycle arrest; EGFR; Gliomagenesis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT; GLIAL FIBRILLARY ACIDIC PROTEIN; NESTIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CELL CYCLE G1 PHASE; GENE; GENE DELETION; GENE TRANSFER; GLIOBLASTOMA; GLIOMA; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

EID: 0032418416     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.23.3675     Document Type: Article

References (12)

1. Bates, P., J.A. Young, and H.E. Varmus. 1993. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor Cell 74: 1043-1051.
2. Chin, L., J. Pomerantz, D. Polsky, M. Jacobson, C. Cohen, C. Cordon-Cardo, J.W.S. Horner, and R.A. DePinho. 1997. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes & Dev.21: 2822-2834.
3. Donehower, L.A., M. Harvey, B.L. Slagle, M.J. McArthur, C.A. Montgomery, J. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
4. Donehower, L.A., L.A. Godley, C.M. Aldaz, R. Pyle, Y.P. Shi, D. Pinkel, J. Grey, A. Bradley, D. Medina, and H.E. Varmus. 1995. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes & Dev. 9: 882-895.
5. Ekstrand, A.J., N. Sugawa, C.D. James, and V.P. Collins. 1992. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc. Natl. Acad. Sci. 89: 4309-4313.
6. Ekstrand, A.J.,N. Longo, M.L. Hamid, J.J. Olson, L. Liu, V.P. Collins, and C.D. James. 1994. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene 9: 2313-2330.
7. Fanning, E. 1992. Modulation of cellular growth control by SV40 large T antigen. In Malignant transformation by DNA viruses (ed. W. Doerfler and P. Bohm), pp. 1-19. VCH, Weinheim, Germany.
8. Hawkins, R.A., E. Killen, I.R. Whine, W.J. Jack, U. Chetty, and R.J. Prescott. 1991. Epidermal growth factor receptors in intracranial and breast tumours: Their clinical significance. Br. J. Cancer 63: 553-560.
9. Hayashi, Y., K. Ueki, A. Waha, O.D. Wiestier, D.N. Louis, and A. von Deimling. 1997. Association of EGFR gene amplification and CDKN2 (p16/MTSl) gene deletion in glioblastoma multiforme. Brain Pathol. 7: 871-875.
10. He, J., J.R. Allen, V.P. Collins, M.J. Allalunis-Turner, R. Godbout, R.S. Day, and C.D. James. 1994. CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma lines. Cancer Res. 54: 5804-5807.
11. He, J., J.J. Olson, and C.D. James. 1995. Lack of p16INK4 or retinoblastoma protein (pRb) or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res. 55: 4833-4836.
12. Holland, E.G. and H.E. Varmus. 1998. Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice. Proc. Natl Acad. Sci. 95: 1218-1223.